Adverse pregnancy outcomes among multi-ethnic systemic lupus erythematosus patients in Malaysia.

Lupus
Syahrul Sazliyana ShaharirRahana A Rahman

Abstract

Despite the improvement in the live birth rate among patients with systemic lupus erythematosus (SLE), they are still at an increased risk of adverse pregnancy outcomes (APOs). To determine the prevalence and factors associated with APOs in the multi-ethnic SLE populations in Malaysia.Methodology: This was a retrospective review of the consecutive SLE patients who attended the outpatient clinic in two major rheumatology centres from January 2016 until December 2019 with complete pre-pregnancy, antenatal and intra-partum records. APOs include pregnancy loss, prematurity, pre-eclampsia, intra-uterine growth restriction (IUGR) and maternal death. Univariate and multivariable logistic regression with generalised estimating equation (GEE) analyses were performed to determine the factors associated with APOs. A total of 153 patients with 240 pregnancies were included and the majority of the patients were Malay (69.9%), followed by Chinese (24.2%) and Indian (5.9%). The prevalence of APOs was 61.7% with the commonest complication being prematurity (28.3%), followed by pregnancy loss (24.6%) and pre-eclampsia (21.8%). Logistic regression model-based GEE analysis revealed that the independent predictors of APOs were active haematologica...Continue Reading

References

Oct 1, 1992·American Journal of Reproductive Immunology : AJRI·M A PetriD W Goldman
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Nov 24, 1999·Lupus·Jill P BuyonMunther A Khamashta
Nov 1, 2006·Arthritis and Rheumatism·Megan ClowseMichelle Petri
Nov 16, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Yiann E ChenCollaborative Study Group
May 6, 2008·American Journal of Obstetrics and Gynecology·Megan ClowseAndra H James
Mar 17, 2010·The Journal of Rheumatology·Dafna GladmanMurray Urowitz
Aug 7, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Andrew SmythVesna D Garovic
Apr 21, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Juntao LiuFengchun Zhang
Oct 25, 2011·International Journal of Medical Sciences·Hyun Sun KoJong Chul Shin
Dec 2, 2011·The New England Journal of Medicine·George C Tsokos
Jan 27, 2012·Clinical Rheumatology·Miguel A SaavedraLuis J Jara
May 5, 2012·Arthritis Care & Research·Bevra H HahnAmerican College of Rheumatology
Nov 19, 2013·Best Practice & Research. Clinical Rheumatology·Aisha Lateef, Michelle Petri
Nov 16, 2014·Immunologic Research·Elisabetta BorellaAndrea Doria
Mar 10, 2015·Journal of the Chinese Medical Association : JCMA·Ming-Jie YangChang-Ching Yeh
Jun 23, 2015·Annals of Internal Medicine·Jill P BuyonJane E Salmon
Nov 12, 2015·Arthritis Care & Research·Carmen V Medina-QuiñonesDavid Isenberg
Jan 28, 2016·Arthritis Care & Research·Megan Clowse, Chad Grotegut
Mar 24, 2017·Open Access Rheumatology : Research and Reviews·Caroline L Knight, Catherine Nelson-Piercy
Sep 5, 2019·Modern Rheumatology·Sayaka TsudaMinistry of Health Labour and Welfare Working Group for “Guideline for The Treatment of Rheumatoid Arthritis or Inflammatory
Mar 5, 2020·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Sukriti BansalNilum Rajora

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.